Open Nav
Open Nav
Check your Inbox
We've sent your certificate
Thank you
for your Feedback!
Activity Overview
Faculty & Disclosures
Infographic
Activity Overview
Faculty & Disclosures
Infographic
Prof. John Oppenheimer
UMDNJ-Rutgers University, NJ
Biography
Prof. Oppenheimer is the Clinical Professor of Medicine at UMDNJ-Rutgers, and Director of Clinical Research at Pulmonary and Allergy Associates. He has also served as the Chairman of the American Board of Allergy and Immunology and is a member of the Joint Task Force of the Practice Parameter Committee for Allergy Immunology. Prof. Oppenheimer is also currently the Executive Editor of the Annals of Allergy Asthma and Immunology journal.
Disclosures
Adjucation Committees and Data Safety Monitoring Boards for Abbvie, AstraZeneca, GSK, Novartis, and Sanofi-Regeneron. Grants and personal fees from GSK. Speaker fees from GSK. Consultant/Advisor for Aquestive, ARS, AstraZeneca/Amgen, DBV, GSK, and Teva.
Prof. Peter Gibson
Prof. William Busse
Prof. William Busse
University of Wisconsin, WI
Biography
Prof. Busse is Professor Emeritus of the Department of Medicine at the University of Wisconsin. He has served as the President of the American Academy of Allergy and Immunology, and Chair of the US National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma. He has also been a member of various national and international guidelines committees for the treatment of asthma, and served on the Advisory Council and Board of External Experts of the National Heart, Lung, and Blood Institute.
Disclosures
Advisory boards for GSK, Regeneron, and Sanofi.
Prof. John Oppenheimer
Prof. Peter Gibson
Prof. Peter Gibson
University of Newcastle, Callaghan
Biography
Prof. Gibson is Professor at the School of Medicine and Public Health at the University of Newcastle, and Respiratory Physician and Clinical Scientist in the Department of Respiratory and Sleep Medicine at John Hunter Hospital, Australia. He serves as Director and Chief Investigator for the Australian National Health and Medical Research Council (NHMRC) Centre of Excellence in Asthma Treatable Traits, and is Project co-Lead of the Australasian Severe Asthma Registry.
Disclosures
Research grants from GSK and Sanofi. Speaker fees from AstraZeneca and GSK. Advisory boards for GSK.
Prof. William Busse
Prof. John Oppenheimer
touchMEETING HIGHLIGHTS
This content is intended for healthcare professionals only.
This activity is sponsored by GSK.
GSK provided financial support and video content, and has had input into the detailed project scope. This activity is provided by Touch Medical Communications (TMC) for touchRESPIRATORY.
Close Popup
Could not verify Country/IP Address.
We were unable to verify your IP address, please try again later. If you are using a method to hide your IP address, such as a VPN or proxy, please disable this and try again.
This activity is sponsored by GSK.
GSK provided financial support and video content (originally broadcasted in partnership with GAA-INTERASMA Global Asthma Association), and has had input into the detailed project scope. This activity is provided by Touch Medical Communications (TMC) for touchRESPIRATORY.
Unapproved products or unapproved uses of approved products may be discussed; these situations may reflect the approval status in one or more jurisdictions. TMC has advised the sponsor to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by TMC of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in TMC activities. TMC accepts no responsibility for errors or omissions.
The views and opinions expressed are those of the faculty and do not necessarily reflect those of any sponsor.
NX-GBL-FVU-WCNT-250003
Date of preparation: October 2025
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.